Publication | Open Access
Chk1 as a new therapeutic target in triple-negative breast cancer
61
Citations
37
References
2014
Year
These findings suggest that Chk1 may represent a therapeutic target in TNBC, and provide a rationale to evaluate Chk1 inhibitors in breast cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1